CLPT
ClearPoint Neuro, Inc.
NASDAQHealthcareMedical - DevicesUS
Rating:D+
Company Profile
CEO
Joseph Michael Burnett
IPO Date
2012-05-22
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
ClearPoint Neuro, Inc.
CEO
Joseph Michael Burnett
IPO Date
2012-05-22
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
| 12,820 |
| $0.00 |
| 26 May 2026 | Klein Matthew B. | director | S-Sale | Disposed | 16,000 | $11.59 |
| 26 May 2026 | Klein Matthew B. | director | A-Award | Acquired | 12,820 | $0.00 |
| 26 May 2026 | Richards Timothy T. | director | A-Award | Acquired | 12,820 | $0.00 |
| 26 May 2026 | FLETCHER R JOHN | director | A-Award | Acquired | 12,820 | $0.00 |
| 26 May 2026 | JOHNSON B KRISTINE | director | A-Award | Acquired | 12,820 | $0.00 |
| 21 May 2026 | Klein Matthew B. | director | M-Exempt | Acquired | 12,417 | $0.00 |
| 21 May 2026 | Klein Matthew B. | director | M-Exempt | Disposed | 12,417 | $0.00 |
| 21 May 2026 | FALLON LYNNETTE C | director | M-Exempt | Acquired | 12,417 | $0.00 |